http://www.healio.com/hematology-oncology/pediatric-oncology/news/online/%7B4f904174-9f98-43bc-8d27-5ef0de8c7c2c%7D/studies-highlight-potential-for-genomic-testing-in-pediatric-cancers
Posts Categorized: About
Genetic Discoveries Prompt Lazarus-Like Recoveries in Cancer Patients
http://www.usnews.com/news/articles/2016-02-24/genetic-discoveries-prompt-lazarus-like-recoveries-in-cancer-patients
Opinion: What A Cancer Cure ‘Moon Shot’ Might Look Like
http://commonhealth.wbur.org/2016/01/opinion-what-a-cancer-cure-moon-shot-might-look-like
Turning your cancer against itself
Turning your cancer against itself
First targeted treatment to improve survival of high-risk patients with acute myeloid leukemia
http://www.news-medical.net/news/20151208/First-targeted-treatment-to-improve-survival-of-high-risk-patients-with-acute-myeloid-leukemia.aspx
A Leap Forward for Precision Cancer Medicine
http://www.usnews.com/news/articles/2015/11/04/wuxi-nextcode-to-sequence-genomes-of-1-000-cancer-patients
The Evolution of Precision Medicine
http://health.usnews.com/health-news/hospital-of-tomorrow/articles/2015/10/20/the-evolution-of-precision-medicine
Brigham and Women’s geneticist receives Lasker award
http://www.brighamandwomens.org/About_BWH/publicaffairs/news/laskeraward.aspx?sub=1
How the way We Fight Cancer Is Changing
http://www.huffingtonpost.ca/dr-james-aw/cancer-drugs-personalized-drugs_b_7646508.html
‘Exceptional responders’ to cancer drugs draw scrutiny from scientists
http://www.washingtonpost.com/national/health-science/looking-for-answers-in-cancers-exceptional-responders/2015/06/13/9cf0ec78-0571-11e5-a428-c984eb077d4e_story.html
New chemical technology boosts potency of targeted cancer therapy
http://www.dana-farber.org/Newsroom/News-Releases/new-chemical-technology-boosts-potency-of-targeted-cancer-therapy.aspx
International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy
http://www.dana-farber.org/newsroom/news-releases/2015/international-study-of-advanced-prostate-cancer-genome-finds-abundance-of-potential-targets-for-drug-therapy/
New drug combination extends survival of patients with metastatic colorectal cancer
http://www.dana-farber.org/Newsroom/News-Releases/new-drug-combination-extends-survival-of-patients-with-metastatic-colorectal-cancer.aspx
New targeted drug promising treatment option in resistant EGFR-positive lung cancers
http://www.dana-farber.org/Newsroom/News-Releases/New-targeted-drug-promising-treatment-option-in-resistant-EGFR-positive-lung-cancers.aspx
Webchat: The Latest in Precision Medicine and Lung Cancer
http://www.dana-farber.org/Health-Library/Webchat–The-Latest-in-Precision-Medicine-and-Lung-Cancer.aspx
Minor gene mutations can produce extensive disruption of protein interactions, study finds
http://www.dana-farber.org/Newsroom/News-Releases/minor-gene-mutations-can-produce-extensive-disruption-of-protein-interactions-study-finds.aspx
Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx
D’Andrea selected to lead new SU2C Ovarian Cancer Dream Team
http://www.dana-farber.org/Newsroom/News-Releases/dana-farbers-dandrea-selected-to-lead-new-su2c-ovarian-cancer-dream-team.aspx
Unregulated web marketing of genetic tests for personalized cancer care raises concerns in new study
http://www.dana-farber.org/Newsroom/News-Releases/Unregulated-web-marketing-of-genetic-tests-for-personalized-cancer-care-raises-concerns-in-new-study.aspx
Novel precision medicine tool could help personalize cancer treatments
http://www.dana-farber.org/Newsroom/News-Releases/novel-precision-medicine-tool-could-help-personalize-cancer-treatments.aspx
Five things you should know about precision medicine
http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-experts-share-five-things-you-should-know-about-precision-medicine.aspx
Study identifies promising drug target in certain breast and ovarian cancers
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-promising-drug-target-in-certain-breast-and-ovarian-cancers.aspx
Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors
http://blog.dana-farber.org/insight/2015/02/collaborative-effort-helps-develop-more-effective-treatment-for-brain-tumors/
Large study catalogs genetic culprits in head and neck cancers
http://www.dana-farber.org/Newsroom/News-Releases/large-study-catalogs-genetic-culprits-in-head-and-neck-cancers.aspx
New Immunotherapy Vaccines Show Promise in Treating Brain Tumors
http://blog.dana-farber.org/insight/2015/01/new-immunotherapy-vaccines-show-promise-in-treating-brain-tumors/
Combined therapy can reduce chance of recurrence in women with small, HER2+ breast tumors, study shows
http://www.dana-farber.org/Newsroom/News-Releases/combined-therapy-can-reduce-chance-of-recurrence-in-women-with-small-her-2-positive-breast-tumors.aspx
Common genetic variations may contribute to treatment-related cognitive problems in children with leukemia
http://www.dana-farber.org/Newsroom/News-Releases/common-genetic-variations-may-contribute-to-treatment-related-cognitive-problems-in-children-with-leukemia.aspx
Disorder in gene-control system is a defining characteristic of cancer, study finds
http://www.dana-farber.org/Newsroom/News-Releases/Disorder-in-gene-control-system-is-a-defining-characteristic-of-cancer-study-finds.aspx
Immunotherapy shows clinical benefit in relapsed transplant recipients
http://www.dana-farber.org/Newsroom/News-Releases/immunotherapy-shows-clinical-benefit-in-relapsed-transplant-recipients.aspx
Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
http://www.dana-farber.org/Newsroom/News-Releases/stem-cell-transplant-without-radiation-or-chemotherapy-pre-treatment-shows-promise.aspx
New test developed at Dana-Farber/Brigham and Women’s Cancer Center speeds treatment decisions for blood cancer patients
http://www.dana-farber.org/Newsroom/News-Releases/new-test-developed-at-dana-farber-brigham-and-womens-cancer-center-speeds-treatment-decisions-for-blood-cancer-patients.aspx
Patient’s dramatic response and resistance to cancer drug traced to unsuspected mutations
http://www.dana-farber.org/Newsroom/News-Releases/patients-dramatic-response-and-resistance-to-cancer-drug-traced-to-unsuspected-mutations.aspx
Unsuspected gene found frequently mutated in colorectal, endometrial cancers
http://www.dana-farber.org/Newsroom/News-Releases/Unsuspected-gene-found-frequently-mutated-in-colorectal-endometrial-cancers.aspx
Researchers identify early sign of pancreatic cancer
http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-early-sign-of-pancreatic-cancer.aspx
New view of stomach cancer could hasten better therapies
http://www.dana-farber.org/Newsroom/News-Releases/New-view-of-stomach-cancer-could-hasten-better-therapies.aspx
Study identifies novel genomic changes in the most common type of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-novel-genomic-changes-in-the-most-common-type-of-lung-cancer.aspx
Scientists Engineer Nanoparticles to Prevent Bone Cancer, Strengthen Bones
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1817
Genomic Technology Enters the Mainstream Practice of Medicine
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1815
Many patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy, researchers report
http://www.dana-farber.org/Newsroom/News-Releases/many-patients-with-rare-gastrointestinal-tumor-receive-long-term-benefit-from-targeted-therapy-researchers-report.aspx
Drug-resistant lung tumors respond to new precision therapy in early-stage trial
http://www.dana-farber.org/Newsroom/News-Releases/Drug-resistant-lung-tumors-respond-to-new-precision-therapy-in-early-stage-trial.aspx
Precision medicine for lung cancer marks tenth anniversary
http://www.dana-farber.org/Newsroom/News-Releases/precision-medicine-for-lung-cancer-marks-tenth-anniversary.aspx
FDA approves first targeted drug for advanced stomach cancer
http://www.dana-farber.org/Newsroom/News-Releases/fda-approves-first-targeted-drug-for-advanced-stomach-cancer.aspx
Genomic testing links ‘exceptional’ drug response to rare mutations in bladder cancer
http://www.dana-farber.org/Genomic-testing-links-exceptional-drug-response-to-rare-mutations-bladder-cancer.aspx
Study reports success in targeted therapy for common form of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/Study-reports-success-in-targeted-therapy-for-common-form-of-lung-cancer.aspx
Targeted therapy boosts lung cancer outcomes
http://www.dana-farber.org/NewsRoom/News-Releases/targeted-therapy-boosts-lung-cancer-outcomes.aspx
Some patients with incurable tumors and BRCA mutations respond to new two-drug combination
http://www.dana-farber.org/Newsroom/News-Releases/some-patients-with-incurable-tumors-and-brca-mutations-respond-to-new-two-drug-combination.aspx
Genomic sequencing identifies mutant ‘drivers’ of common brain tumor
http://www.dana-farber.org/Newsroom/News-Releases/Genomic-sequencing-identifies-mutant-drivers-of-common-brain-tumor.aspx
Find Clinical Trials
To find clinical trials that focus on targeted therapies, use the pulldown menus below or enter a term in the search box.
Request a Consultation
To schedule a consultation with an oncologist at Dana-Farber/Brigham and Women's Cancer Center, please call one of our experienced appointment coordinators.
